Rapid defervescence after doxycycline treatment of macrolide-resistant mycoplasma pneumoniae-associated community-acquired pneumonia in children

Pediatric Infectious Disease Journal

Volumn 32, Issue 12, 2013, Pages 1396-1399

  Lung, David Christopher ^a   Tong, Eric Kam ^a   Yan Lam, David Shu ^a   Que, Tak Lun ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Doxycycline; Macrolide resistant; Mycoplasma pneumoniae; Pneumonia

Indexed keywords

DOXYCYCLINE; LEVOFLOXACIN; MACROLIDE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFICACY; FEMALE; FEVER; HOSPITALIZATION; HOSPITALIZED CHILD; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; YOUNG ADULT; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; HONG KONG; MICROBIOLOGY; PNEUMONIA, MYCOPLASMA; RETROSPECTIVE STUDY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; FEVER; HONG KONG; HUMANS; MACROLIDES; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; RETROSPECTIVE STUDIES;

EID: 84891737539     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182a25c71     Document Type: Article

References (15)

1. Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45:617-620.
2. Bébéar C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6:423-431.
3. Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother. 2009;53:2158-2159.
4. Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother. 2009;53:2160-2162.
5. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis. 2010;51:189-194.
6. Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57:1521-1523.
7. Lung DC, Chan YH, Kwong L, et al. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Hong Kong Medical J. 2011;17:407-409.
8. Kawai Y, Miyashita N, Yamaguchi T, et al. Clinical effcacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneu-moniae pneumonia in paediatric patients. Respirology. 2012;17:354-362.
9. Hardegger D, Nadal D, Bossart W, et al. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods. 2000;41:45-51.
10. Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48: 4624-4630.
11. Saegeman V, Proesmans M, Dumke R. Management of macrolide-resistant Mycoplasma pneumoniae infection. Pediatr Infect Dis J. 2012;31:1210-1211.
12. Kawai Y, Miyashita N, Kubo M, et al. Therapeutic effcacy of macrolides, minocycline, and tosufoxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother. 2013;57:2252-2258.
13. Okada T, Morozumi M, Tajima T, et al. Rapid effectiveness of minocy-cline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642-1649.
14. Forti G, Benincori C. Doxycycline and the teeth. Lancet. 1969;1:782.
15. Volovitz B, Shkap R, Amir J, et al. Absence of tooth staining with doxycy-cline treatment in young children. Clin Pediatr (Phila). 2007;46:121-126.